imatinib mesylate has been researched along with Paraneoplastic Syndromes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Luvira, V; Pairojkul, C; Wannasri, T | 1 |
| Dutta, PK; Mandal, C | 1 |
| Cuthbert, RJ; Furby, D; McMullin, MF; McNicholl, F; Ramanujam, D; Richardson, D | 1 |
| Baybay, H; Berrady, R; Bono, W; El Hatimi, A; Gallouj, S; Khammar, Z; Lahlou, M; Lamchachti, L; Mernissi, FZ | 1 |
| Knipp, H; Kretzschmar, A; Lindner, T; Pink, D; Reichardt, P; Schoeler, D; Thuss-Patience, PC; Vanhoefer, U | 1 |
| Fanucchi, M; Folpe, A; Guiteau, J; Kooby, DA; Staley, CA | 1 |
6 other study(ies) available for imatinib mesylate and Paraneoplastic Syndromes
| Article | Year |
|---|---|
Dramatic disappearance of hyperglycemia and abnormal neurologic symptoms after resection of duodenal gastrointestinal stromal tumor.
Topics: Aged; Duodenum; Female; Gastrointestinal Stromal Tumors; Humans; Hyperglycemia; Imatinib Mesylate; Paraneoplastic Syndromes | 2022 |
GIST (ILEAL) Revealed by Peculiar Paraneoplastic-myositis and Hypo-Thyroidism.
Topics: Autoantibodies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Myositis; Paraneoplastic Syndromes; Thyrotropin | 2023 |
Dramatic resolution of respiratory symptoms with imatinib mesylate in patients with chronic myeloid leukemia presenting with lower airway symptoms resembling asthma.
Topics: Adult; Antineoplastic Agents; Asthma, Exercise-Induced; B-Lymphocytes; Benzamides; Cough; Diagnostic Errors; Dyspnea; Exercise; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Leukotriene C4; Male; Paraneoplastic Syndromes; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Remission Induction | 2009 |
[Acquired ichthyosis and haematological malignancies: five cases].
Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematologic Neoplasms; Hodgkin Disease; Humans; Ichthyosis; Imatinib Mesylate; Leukemia, Myeloid, Accelerated Phase; Lung Neoplasms; Lymphoma, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Parotid Neoplasms; Piperazines; Platelet Aggregation Inhibitors; Prednisone; Procarbazine; Pyrimidines; Retrospective Studies; Rituximab; Schizophrenia; Stomach Neoplasms; Vincristine | 2012 |
Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two cases.
Topics: Abdominal Pain; Adult; Benzamides; Blood Glucose; Combined Modality Therapy; Digestive System Surgical Procedures; Follow-Up Studies; Gastrointestinal Stromal Tumors; Glucose; Humans; Hypoglycemia; Imatinib Mesylate; Insulin-Like Growth Factor II; Intestine, Small; Male; Middle Aged; Paraneoplastic Syndromes; Piperazines; Pyrimidines; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
Hypoglycemia in the setting of advanced gastrointestinal stromal tumor.
Topics: Abdominal Neoplasms; Aged; Antineoplastic Agents; Benzamides; Blood Glucose; Diagnosis, Differential; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Hypoglycemia; Imatinib Mesylate; Leiomyosarcoma; Neoplasm Recurrence, Local; Palliative Care; Paraneoplastic Syndromes; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines | 2006 |